ALICE SHACKELFORD: Open Payments
NPI 1316653397 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,330 in 140 payments from 15 companies in 2025. Trend: 2023 $2,525 · 2024 $3,238 · 2025 $2,330
Food & beverage: $2,330
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $534 |
| Amgen Inc. | 35 | $402 |
| Novartis Pharmaceuticals Corporation | 18 | $290 |
| UCB, Inc. | 11 | $219 |
| Janssen Biotech, Inc. | 12 | $189 |
| Mallinckrodt Hospital Products Inc. | 4 | $112 |
| ANI Pharmaceuticals, Inc. | 6 | $111 |
| Radius Health, Inc. | 4 | $110 |
| AstraZeneca Pharmaceuticals LP | 6 | $90 |
| E.R. Squibb & Sons, L.L.C. | 4 | $79 |
Products named: SKYRIZI, COSENTYX, Bimzelx, TREMFYA, RINVOQ, OTEZLA, ACTHAR, PURIFIED CORTROPHIN GEL.
Industry payments across MS — which companies pay providers there.
